Home > Insider Trading > Filing (0001225208-10-009369)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901458	M Peter Nicholas	One Boston Scientific Place Natick MA 01760-1537		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-30	25,000	$7.14	9,931,021	No	4	S	Indirect	By Ltd. Partnership
Common Stock	Disposition	2010-03-30	100,000	$0.00	9,831,021	No	4	J	Indirect	By Ltd. Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Ltd. Partnership
No	4	J	Indirect	By Ltd. Partnership

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Forward Sale Contract	Disposition	2010-03-30	100,000	$0.00	100,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-03-30	2010-03-30	No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,193,128	Direct
Common Stock	2,413,088	Indirect	By Trust 2

Footnotes

Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.26 to $7.05. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
On March 30, 2010, a family limited partnership of which the reporting person is a general and limited partner, Promerica L.P., settled a prepaid variable forward sale contract entered into on March 30, 2009 with an unaffiliated commercial bank. At the initiation of the contract, the bank paid $582,487.58 to Promerica. The contract obligated Promerica to deliver to the bank up to 100,000 shares of the Issuer's common stock depending on market prices at maturity. If the market price per share at maturity was equal to or less than the floor price of $7.98 per share, the reporting person would deliver 100,000 shares to the bank. If the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. The market price per share on March 30, 2010 was less than $7.98. Accordingly, the reporting person transferred to the bank 100,000 shares of the Issuer's common stock.
Shares held by a trust of which the reporting person's spouse and brother are trustees and the reporting person's spouse and children are beneficiaries.